Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Thomas C. Westfall"'
Autor:
Thomas C. Westfall, Martin C. Michel, Dan Larhammar, Herbert Herzog, William F. Colmers, Thue W. Schwartz, Rémi Quirion, Helen M. Cox, Annette G. Beck-Sickinger, Henri Doods
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2019
Neuropeptide Y (NPY) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Neuropeptide Y Receptors [156]) are activated by the endogenous peptides neuropeptide Y, neuropeptide Y-(3-36), peptide YY, PYY-(3-36) and pancreatic polypeptide
Publikováno v:
Acta Physiologica. 203:37-45
Noradrenaline, neuropeptide Y and adenosine triphosphate are co-stored in, and co-released from, sympathetic nerves. Each transmitter modulates its own release as well as the release of one another; thus, anything affecting the release of one of thes
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 298:H457-H465
Neuropeptide Y (NPY) is a cotransmitter with norepinephrine (NE) and ATP in sympathetic nerves. There is evidence for increased activity of the sympathetic nervous system and the renin-angiotensin system (RAS), as well as a role for NPY in the develo
Publikováno v:
NeuroToxicology. 30:1030-1035
Parkinson disease is a specific form of neurodegeneration characterized by a loss of nigra-striatal dopaminergic neurons in the midbrain of humans. The disease is also characterized by an increase in oxidative stress and a loss of glutathione in the
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 295:H2188-H2197
The sympathetic nervous system and renin-angiotensin system are both thought to contribute to the development and maintenance of hypertension in experimental models such as the spontaneously hypertensive rat (SHR). We demonstrated that periarterial n
Publikováno v:
Biochemical Pharmacology. 73:1446-1454
In rat pheochromocytoma (PC12) cells the dopamine D(2) receptor agonists apomorphine (APO) and n-propylnorapomorphine (NPA) produced a concentration dependent inhibition of K(+)-evoked neuropeptide Y release (NPY-ir). The effect of APO was blocked by
Publikováno v:
Neuropharmacology. 52:1396-1402
The purpose of the present study was to determine whether or not activation of neuropeptide Y (NPY) receptors resulted in an enhancement or attenuation of the KCl (50 mM) evoked release of [3H]dopamine newly synthesized from [3H]tyrosine in superfuse
Publikováno v:
Journal of Cardiovascular Pharmacology. 47:723-728
The effect of neuropeptide Y (NPY) on the basal and nerve stimulation-induced increase in norepinephrine synthesis was studied in the isolated and perfused mesenteric arterial bed of the rat. Tyrosine hydroxylation, the rate-limiting step in catechol
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 286:H296-H303
Nitric oxide (NO) reacts with catecholamines resulting in their deactivation. In this study, we demonstrated that coincubation of NO donors with sympathetic neurotransmitters decreased the amount of norepinephrine detected but not ATP or neuropeptide
Publikováno v:
Autonomic and Autacoid Pharmacology. 23:141-147
Summary 1 A variety of prostanoids were examined for their ability to alter the periarterial nerve stimulation-induced release of noradrenaline (NA) and neuropeptide Y immunoreactive compounds (NPY-ir) from the perfused mesenteric arterial bed of the